Callan Family Office’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$506K	Buy	+30,191	New	+$506K	0.02%	581
2025 Q1	–	Sell	-9,389	Closed	-$207K	–	640
2024 Q4	$207K	Buy	+9,389	New	+$207K	0.01%	595